141 related articles for article (PubMed ID: 11836714)
1. Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study.
Dagher R; Long LM; Read EJ; Leitman SF; Carter CS; Tsokos M; Goletz TJ; Avila N; Berzofsky JA; Helman LJ; Mackall CL
Med Pediatr Oncol; 2002 Mar; 38(3):158-64. PubMed ID: 11836714
[TBL] [Abstract][Full Text] [Related]
2. Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumors.
van den Broeke LT; Pendleton CD; Mackall C; Helman LJ; Berzofsky JA
Cancer Res; 2006 Feb; 66(3):1818-23. PubMed ID: 16452243
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas.
Mackall CL; Rhee EH; Read EJ; Khuu HM; Leitman SF; Bernstein D; Tesso M; Long LM; Grindler D; Merino M; Kopp W; Tsokos M; Berzofsky JA; Helman LJ
Clin Cancer Res; 2008 Aug; 14(15):4850-8. PubMed ID: 18676758
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumor specific translocations in sarcomas in pediatric patients for immunotherapy.
Mackall C; Berzofsky J; Helman LJ
Clin Orthop Relat Res; 2000 Apr; (373):25-31. PubMed ID: 10810459
[TBL] [Abstract][Full Text] [Related]
5. Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies.
Knott MML; Hölting TLB; Ohmura S; Kirchner T; Cidre-Aranaz F; Grünewald TGP
Cancer Metastasis Rev; 2019 Dec; 38(4):625-642. PubMed ID: 31970591
[TBL] [Abstract][Full Text] [Related]
6. RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
Thomson B; Hawkins D; Felgenhauer J; Radich J
Bone Marrow Transplant; 1999 Sep; 24(5):527-33. PubMed ID: 10482938
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas.
Merchant MS; Bernstein D; Amoako M; Baird K; Fleisher TA; Morre M; Steinberg SM; Sabatino M; Stroncek DF; Venkatasan AM; Wood BJ; Wright M; Zhang H; Mackall CL
Clin Cancer Res; 2016 Jul; 22(13):3182-91. PubMed ID: 26823601
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics and experimental models of sarcomas.
Fletcher JA
Curr Opin Oncol; 1994 Jul; 6(4):367-71. PubMed ID: 7803537
[TBL] [Abstract][Full Text] [Related]
9. Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA.
Hayashi M; Chu D; Meyer CF; Llosa NJ; McCarty G; Morris CD; Levin AS; Wolinsky JP; Albert CM; Steppan DA; Park BH; Loeb DM
Cancer; 2016 Oct; 122(19):3015-23. PubMed ID: 27351911
[TBL] [Abstract][Full Text] [Related]
10. A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group.
Baruchel S; Pappo A; Krailo M; Baker KS; Wu B; Villaluna D; Lee-Scott M; Adamson PC; Blaney SM
Eur J Cancer; 2012 Mar; 48(4):579-85. PubMed ID: 22088484
[TBL] [Abstract][Full Text] [Related]
11. Multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing's sarcoma.
Downing JR; Khandekar A; Shurtleff SA; Head DR; Parham DM; Webber BL; Pappo AS; Hulshof MG; Conn WP; Shapiro DN
Am J Pathol; 1995 Mar; 146(3):626-34. PubMed ID: 7887445
[TBL] [Abstract][Full Text] [Related]
12. Ewing sarcoma: biology-based therapeutic perspectives.
Potratz J; Jürgens H; Craft A; Dirksen U
Pediatr Hematol Oncol; 2012 Feb; 29(1):12-27. PubMed ID: 22304007
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
[TBL] [Abstract][Full Text] [Related]
14. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
[TBL] [Abstract][Full Text] [Related]
15. [Comparison and analysis of different dendritic cell-based immunotherapeutic strategies for Ewing sarcoma: in vitro and in vivo induction on SCID mouse models].
Zhao H; Tang S; Qu HY; Guo W; Li X; Peng CL
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 39(4):403-8. PubMed ID: 17657269
[TBL] [Abstract][Full Text] [Related]
16. Primary subcutaneous spindle cell Ewing sarcoma with strong S100 expression and EWSR1-FLI1 fusion: a case report.
Arnold MA; Ballester LY; Pack SD; Abdullaev Z; Merchant M; Tsokos MG
Pediatr Dev Pathol; 2014; 17(4):302-7. PubMed ID: 24735198
[TBL] [Abstract][Full Text] [Related]
17. Lack of effective T-lymphocyte response to the PAX3/FKHR translocation area in alveolar rhabdomyosarcoma.
Rodeberg DA; Nuss RA; Heppelmann CJ; Celis E
Cancer Immunol Immunother; 2005 Jun; 54(6):526-34. PubMed ID: 15838707
[TBL] [Abstract][Full Text] [Related]
18. PAX immunoreactivity identifies alveolar rhabdomyosarcoma.
Sullivan LM; Atkins KA; LeGallo RD
Am J Surg Pathol; 2009 May; 33(5):775-80. PubMed ID: 19145202
[TBL] [Abstract][Full Text] [Related]
19. Next steps in preventing Ewing sarcoma progression.
Knott MM; Dallmayer M; Grünewald TG
Future Oncol; 2016 Jan; 12(1):1-4. PubMed ID: 26615856
[No Abstract] [Full Text] [Related]
20. Panhandle PCR for cDNA: a rapid method for isolation of MLL fusion transcripts involving unknown partner genes.
Megonigal MD; Rappaport EF; Wilson RB; Jones DH; Whitlock JA; Ortega JA; Slater DJ; Nowell PC; Felix CA
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9597-602. PubMed ID: 10920186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
